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Diagnosing acute kidney injury remains a challenge since the established renal 
biomarkers, serum creatinine (sCr) and symmetric dimethylarginine (SDMA) reflect 
glomerular function and not tubular injury. Sensitive tubular markers such as urinary 
clusterin (uClust) and cystatin B (uCysB) have been proposed to detect AKI at an earlier 
stage. Since envenomation by the European adder (Vipera berus berus) could serve as a 
spontaneous disease model of AKI we investigated these new biomarkers in affected dogs. 
Concentrations of uClust and uCysB as well as sCr and SDMA were analyzed retrospectively 
in stored samples from 26 dogs with snake envenomation and 13 healthy controls. Higher 
concentrations of uClust (P < 0.012) and uCysB (P < 0.001) were observed in the snake-
envenomed group. Normalization of uClust and uCysB to urinary creatinine did not alter the 
results. No differences were observed in sCr and SDMA between the snake-envenomed 
group and the healthy control group. Spearman rank correlation analysis revealed a strong 
association of uClust with uCysB in the snake-envenomed dogs (r = 0.75 P < 0.001) but not 
in the healthy controls. The high percentage of snake-envenomed dogs with increased uClust 
and uCysB concentrations in the absence of increased sCr and SDMA suggests renal tubular 
injury in the affected dogs. Larger prospective case-controlled studies are warranted to 








Diagnosing acute kidney injury remains a challenge since the standard biomarkers, 
urea and creatinine, reflect kidney function and not tubular injury. Loss of kidney function, 
measured as a decrease in glomerular filtration rate (GFR), is not detectable immediately 
after AKI with surrogate markers of GFR (Endre et al., 2011). Subclinical kidney injury can 
also occur without reduction of GFR (Vanmassenhove et al., 2019). Further, sCr is an 
insensitive marker of GFR alterations and does not become increased above reference until a 
large fraction of kidney function already is lost (Finco 1997).  
The lack of early and robust diagnostic tests for AKI has resulted in an intense search 
of new biomarkers to enable earlier diagnosis and earlier intervention to prevent further 
injury (Hokamp et al., 2016; Parikh et al., 2017). Two novel AKI biomarkers, urinary 
clusterin (uClust) and urinary cystatin B (uCysB) have been shown to be sensitive for 
detection of gentamicin-induced renal proximal tubular toxicity (Yerramilli et al., 2016). 
Further, dogs with AKI caused by leishmaniasis or hemorrhagic shock treated with colloids 
showed increased uClust ( Boyd et al., 2019; Garcia-Martinez et al., 2012). Clusterin is a 76-
80 kDa protein that is expressed in numerous other tissues in addition to renal tissue. The 
glycosylation pattern is different between kidney specific clusterin and the plasma isoform, 
making it possible to measure kidney specific uClust (Yerramilli et al., 2016). Cystatin B has 
previously been purified from supernatant collected from ruptured canine kidney cells but not 
from stressed kidney cells (Yerramilli et al., 2016). The same authors report, that cystatin 
B found in the serum or urine originates from ruptured kidney cells, which in active kidney 
injury most likely is due to apoptosis and necrosis of epithelial cells in the proximal tubule. 
The venom of the European adder (Vipera berus berus) consists of a mixture of 
approximately 25 different proteins and peptides with hemotoxic activity and to a lesser 
extent neuro-, myo-, and cytotoxic properties (Bocian et al., 2016). The envenomation may 
cause a number of clinical and biochemical alterations including changes in renal parameters 
in a subset of affected dogs. The Veterinary Poisons Information Center in the UK reported 
422 dogs with envenomation by V. berus berus. Of the envenomed dogs, 3.4% showed renal 
pathology (increased creatinine, urea, hematuria or renal failure) and the mortality rate was 
4.6% (Sutton et al., 2011). On the other hand, in a Swedish cohort comprising 53 dogs, none 
of the affected patients died nor had increases in sCr values above reference intervals (Lervik 
et al., 2010). The effect of adder venom on canine kidneys has been investigated in more 
detail in two studies that suggested envenomation by the European adders have nephrotoxic 
properties in dogs (Palviainen et al., 2012; Palviainen et al., 2013). Urinary alpha-1-
antitrypsin and beta-2-microglobulin concentrations were higher in the urine of envenomed 
dogs in comparison to healthy controls suggesting tubular injury (Palviainen et al., 2012). 
Also the urinary ratios of -glutamyl transpeptidase/creatinine (uGgt/ uCr), alkaline 
phosphatase (uAlp/ uCr), and protein/creatinine (UPC) were significantly higher in 
envenomed dogs, indicating renal injury (Palviainen et al., 2013). However, uGgt/ uCr and 
uAlp/ uCr ratios did not differ between AKI and chronic kidney disease in another study 
(Nivy et al., 2017).  
Two previous studies in dogs envenomed by adders (Vipera berus berus and Vipera 
palestinae) reported that clinical signs were more severe in dogs with bites on limbs 
compared to those with bites on other parts of the body (Segev et al., 2004; Vestberg et al., 
2017). However, the effect of location and the time between sample collection and snake bite 
on kidney biomarkers have not been studied in dogs bitten by Vipera berus berus.  
When treating dogs envenomed by adders, colloids have been used to stabilize the 
hemodynamics in critically ill patients. However, recent studies have raised concern about 
colloids causing AKI (Boyd et al., 2019; Hayes et al., 2016; Moeller et al., 2016). 
The primary objective of this study was to investigate whether dogs bitten by the 
European adder show increased urinary concentrations of two novel tubular markers, uClust 
and uCysB as a possible sign of AKI in dogs. The secondary objectives were to investigate 
whether these novel tubular biomarkers correlate with established biomarkers of renal 
glomerular function (sCr and SDMA). 
 
Materials and methods 
Study population 
In this descriptive retrospective cohort study, stored serum and urine samples were 
used from a previous study that included 31 client-owned dogs with a high suspicion of 
envenomation by V. berus berus and treated at the University of Helsinki Veterinary 
Teaching Hospital during 2009 (Palviainen et al., 2013). The suspicion of a snake bite was 
based either on the owner observing the adder bite or observing an adder close to the dog and 
typical signs such as swelling and pain of the bitten area. Dogs with a known history of renal 
disease were excluded. Four dogs in the snake- envenomed group were excluded from this 
study due to an unlikely snake bite based on thorough evaluation of all medical records (n = 
4), one had a history of previous azotemia (n=1) and in one case there was insufficient 
sample volume (n=1). Thus, serum and urine samples of 25 dogs with confirmed 
envenomation remained in the study. 
 In 2019, serum and urine samples were collected from an additional 13 dogs who 
were identified as healthy based on physical examination, complete blood count, blood 
chemistry profile and urinalysis. Sampling of healthy dogs was approved by the Animal 
Experiment Board in Finland (ESAVI/3381/04.01.07/2017). All owners of the participants 
gave their written informed consent. 
Sample handling 
Blood and urine samples were collected from snake-envenomed dogs during 
hospitalization. Time from envenomation to sample collection and location of snake bite 
were recorded as well as administration of colloids. Serum was separated after centrifugation 
(1300 g, 10 min, and room temperature). The serum concentration of sCr in envenomed dogs 
was originally measured using a clinical chemistry analyzer (Konelab 30i, Thermo Fisher). 
For this study, sCr concentrations from envenomed dogs were re-measured after storage by a 
colorimetric method, Jaffe’s reaction using picrate at alkaline pH (AU680 Chemistry 
Analyzer, Beckman Coulter, Inc.) and compared with previous test results to assess the 
influence of storage on the results of the new analysis. There was a high correlation for sCr 
analyzed in Helsinki (2009) and at IDEXX Laboratories (2019) (Spearman’s  = 0.87, P 
<0.001). Serum from healthy control dogs was analyzed using a clinical chemistry analyzer 
(AU680 Chemistry Analyzer, Beckman Coulter, Inc.). SDMA was determined using a 
validated, commercially available, high-throughput immunoassay (IDEXX SDMA® Test, 
IDEXX Laboratories, Inc.). 
Voided, free-catch urine samples were collected from envenomed dogs while urine 
samples from healthy controls were either voided or collected by ultrasound guided 
cystocentesis. Urinary creatinine and protein concentrations were measured using routine 
laboratory methods. All serum and urine samples were stored in -80 C until analyses. 
Concentrations of uClust and uCysB were measured using sandwich format immunoassays as 
previously described by Yerramilli et al (Yerramilli et al., 2016). 
Statistical analysis  
All data were calculated using an open source available software (R version 3.6.1. for 
Windows). Spearman rank correlation was performed to compare associations for all 
biomarkers against each other. Significance testing for the Spearman rank correlation was 
done to test for a slope of zero. The Wilcoxon rank sum test was used to compare the 
distributions of the continuous variables between the snake-envenomed and healthy control 
populations. When normalization by urinary creatinine was used, it was noted. Ordinary least 
squares regression was performed to understand the changes in the AKI markers according to 
location and time of the snakebite. Residuals were graphically analysed to assess uniformity, 
and transformation was not necessary. Statistical significance was defined as P < 0.05.  
The acute kidney injury markers uClust and uCysB were analyzed. In this study 
population, 10/13 (76.9%) of the healthy controls and 10/25 (40.0%) of the snakebite sample 
had uClust values below the limit of quantification (LOQ = 70 ng/mL) for the assay. For 
uCysB, 9/13 (69.2%) of healthy controls and 5/25 (20.0%) of snake-envenomed dogs had 
values below the limit of quantification for the assay (LOQ = 45 ng/mL). With such a large 
number of values below the limit of quantification, advanced imputation methods such as 
mixture models or multiple imputation led to erroneous values far above the limit of 
quantification (which is bounded by 0 and the LOQ for the assay). For this reason and to be 
conservative in our comparisons, the values below the LOQ were imputed using the LOQ 




Twenty-five dogs with snake envenomation and 13 healthy controls were included in 
the study. Differences in the age distribution were found between the snake-envenomed 
group (median: 3.8 years, IQR: 1.9 – 7.4) and healthy controls (median: 6.7 years, IQR: 3.8 – 
9.9, Wilcoxon Rank Sum Test P < 0.023; Table 1). No differences were observed in the 
distribution of the weights between the snake-envenomed group (median: 19.0 kg, IQR: 9.4 – 
25.7) and healthy control (median: 22.5 kg, IQR: 8.7 – 29.1, Wilcoxon Rank Sum Test P = 
0.451; Table 1).  
Routine serum renal markers and novel urinary renal biomarkers 
When comparing the biomarkers between the snake-envenomed and healthy dogs, 
uClust was higher in the snake-envenomed dogs, regardless of normalization by uCr 
(Wilcoxon Rank Sum Test P < 0.012; Table 1; Fig. 1). Similarly, uCysB was higher in the 
snake-envenomed group than the healthy control group, whether or not urinary normalization 
factors were used (Wilcoxon Rank Sum Test P < 0.001; Table 1; Fig. 2). No differences in 
the renal biomarkers sCr (P = 0.948) and SDMA (P = 0.994) between the two groups were 
observed, respectively (Table 1; Fig.3). Urine protein: creatinine was higher in the snake-
envenomed group (P = 0.001; Table 1).  
An association was found between UPC and both urinary AKI markers with and 
without normalization for uCr (Spearman’s uClust = 0.511, P < 0.015, Spearman’s uCysB = 
0.671, P < 0.001; Table 2). In envenomed dogs sCr was positively correlated to uClust, but 
this finding was not observed when normalizing uClust with uCr. A negative correlation was 
found between sCr and uClust/uCr in healthy dogs, not observed when not normalizing 
uClust to uCr. Neither of the renal biomarkers sCr and SDMA were correlated with uCyst B 
regardless of normalization for uCr in either the healthy control or snake-envenomed group 
(Table 2).  
 Location of snakebite was evaluated by descriptive statistics with most of the 
bites occurring on the head (n = 16) and limbs (n= 8) and the least on the neck (n = 1). When 
comparing serum and urinary biomarker levels between the regions of the snakebite (head, 
limb), no differences in the distributions between head and limbs were observed for sCr, 
SDMA or uClust (Table 3). However, differences were observed between uCysB levels in 
dogs with snake bites in the head and limb (Wilcoxon Rank Sum Test P < 0.012; Table 3).  
 Time from envenomation was weakly correlated with uClust (Spearman’s  = 
0.521, P <0.009). In contrast, uCysB was not correlated with time from envenomation 
(Spearman’s  = 0.241, P=0.256; Table 4). 
 A total of 28.0% (7/25) of the snake-envenomed dogs received colloidal 
treatment with 4% succinylated gelatin (gelo, Gelofusine B. Braun Melsungen AG). Higher 
concentrations in both uClust and uCysB were observed within the gelo group compared to 
the non- colloidal group (Wilcoxon Rank Sum Test P < 0.005; Figs. 4A, B). There was no 
significant difference in the time from envenomation to sample collection between the gelo 
group (median: 1.90 days, IQR: 1.14 – 2.75) and the non- colloidal group (median: 0.92 days, 
IQR: 0.84 – 2.00, Wilcoxon Rank Sum P = 0.174). Neither were there differences in clinical 
outcome nor in sCr and SDMA in the gelo and the non- colloidal groups.  (Figs. 4 C, D). 
 
Discussion 
The novel renal tubular AKI biomarkers uClust and uCysB were significantly higher 
in the group of dogs bitten by the European adder compared to healthy control dogs.  Further, 
uClust and uCysB were strongly correlated to each other in the snake-envenomed group but 
not in the control group.  These findings suggest renal tubular injury in dogs envenomed by 
European adders. Concentrations of sCr and SDMA, both surrogate markers of GFR, were 
not observed to be different between the two groups nor to be correlated to uClust or uCysB. 
Thus, envenomation by the common European adder results primarily in subclinical AKI, but 
not necessarily in decreased renal function measured as increases in sCr and SDMA.  In 
human medicine, elevations of tubular injury biomarkers in the absence of changes in 
traditional biomarkers of renal function (sCrea and UO), were shown to have an association 
with adverse outcomes (Haase et al., 2011; Joannidis et al., 2019; Nickolas et al., 2012). 
Recent studies also revealed worse outcomes in AKI patients being either under- or 
especially over hydrated (Bagshaw et al., 2008; Mehta et al., 2016; Salahuddin et al., 2017). 
Whether biomarkers of AKI could be used to support treatment decisions e.g. against the use 
of potentially nephrotoxic agents such as NSAIDs and colloids in dogs, still needs to be 
studied. Also, the possible support of AKI biomarkers for evaluating intravenous fluid 
therapy requires further investigation, as it has been routinely used as a part of the supportive 
therapy for eg. snake envenomed dogs.  
 The region of the snake bite did not play a major role in changes in AKI biomarkers 
in our study. Interestingly, two previous studies reported more severe clinical signs in dogs 
bitten on the limbs compared to other areas of the body. In the first study, 8/17 dogs bitten by 
V. berus berus, developed cardiac arrhythmias. Four of these dogs had bites on the limbs and 
all four became arrhythmic (Vestberg et al., 2017). In the second study, dogs bitten by Vipera 
palasteniae, a close relative to Vipera berus berus, showed an increased mortality rate in 
dogs bitten on limbs compared to other areas of the body (Segev et al., 2004). The authors 
suggest that it might be possible that limb envenomation enables a wider and more rapid 
toxin distribution throughout the body compared to bites on for example the head, where 
more soft tissue is capable of absorbing the venom. In our study, we found that only uCysB 
but not uClust, sCr or SDMA concentrations were higher in dogs bitten in the limbs 
compared to bites on the head. One reason for the lack of an association between bite site and 
elevation in uClust could be explained by either a possibly slower increase of this biomarker 
compared to uCysB or the study being too underpowered to draw conclusion on this aspect. 
Since in most cases the samples were collected soon after the bite, future studies should focus 
on repeated sampling for a longer period to investigate the aspect of different timely 
elevations of urinary AKI biomarkers.  
In this study, time from snake envenomation to sample collection varied between 2.5 
h and 4 days but did not have a significant effect on uClust or uCysB levels. There are 
currently no published data regarding the volume of distribution and half-life of the toxic 
components of V. berus berus toxin in dogs. It can be speculated that the lack of decrease in 
uClust and uCysB with increased time from envenomation could be due to the toxin having a 
long half-life, exerting its toxic effects for a prolonged period of time. It might also reflect an 
ongoing active process initiated by the envenomation.  The half-lives of uClust and uCysB 
have not been studied in dogs so far, and long biomarker half-lives could also explain our 
finding. Further studies are needed to understand this better.  
More than one fourth (28%) of the snake-envenomed dogs were treated with gelo 
infusion in addition to crystalloids. The AKI markers were statistically significantly higher in 
these patients in comparison to non-colloid treated dogs. There were no differences in clinical 
outcome between the gelo and the non- colloidal groups. A previous study reported an effect 
of colloids on renal health and gelo administration was shown to increase uClust levels in a 
set of dogs with hemorrhage induced shock (Boyd et al., 2019). However, due to the 
retrospective nature of this study, the indication for colloid treatment was not known. The 
differences in the gelo group could be due to the treatment or that the patients were at a more 
critical condition leading to the use of gelo in addition to crystalloid infusion. These findings 
have anyhow no effect on the interpretation of the urinary biomarker results and can therefore 
be regarded as minor limitations. 
The UPC was higher in the snake-envenomed group compared to the group of healthy 
controls. Previous studies in humans and dogs with snake bites have shown similar findings 
(Hrovat et al., 2013; Kanjanabuch et al., 2008; Palviainen et al., 2012). Proteins in the urine 
can be filtered plasma proteins or originate from the kidneys and the lower urinary tract. 
Primary glomerular dysfunction results in abnormal leakage of high and intermediate 
molecular weight proteins into the urine. Small and to some extent intermediate molecular 
weight proteins are however freely filtered thru intact glomerular filtration barriers and are 
absorbed by the proximal tubules in health. Tubular damage results in inability to reabsorb 
low molecular weight proteins and leads to leakage of proteins from injured epithelial cells 
into urine (D'Amico et al., 2003). Measurement of UPC cannot be used to determine the type 
or origin of proteins (De Loor et al., 2013). Thus, based on our data, we cannot exclude 
concurrent glomerular dysfunction in addition to tubular damage, albeit this seems unlikely 
given the observed low magnitude proteinuria (Littman et al., 2013).   
There are a number of limitations in our study. The samples from both groups were 
stored at -80 C° but samples from envenomed dogs were stored for 10 years.  This could have 
influenced the results. However, the values of the investigated biomarkers are on average 
higher in the archived samples than in the samples from control dogs reducing the likelihood 
that the storage time was of influence on the results. The healthy controls consisted of 
randomly selected dogs owned by staff members of the University of Helsinki Veterinary 
Teaching Hospital. They were older than the snake-envenomed dogs. It is unlikely that the 
age difference between the two groups affected the outcome of this study, since the risk of 
having an underlying chronic kidney disease is greater in older dogs (O'Neill et al., 
2013). Only single point samples were used in this study. The sensitivity of sCr in detecting 
AKI is higher with serial monitoring and using cut off values of increases in sCr of 26.4  
μmol/L (0.3 mg/dL) as proposed by the International Renal Interest Society’s guidelines 
(International Renal Interest Society 2016). Future studies should include serial monitoring of 
sCr that might reveal possible functional decline in dogs envenomed by the European adder. 
Lastly, between 20% and 77% of samples had values that were below the limit of 
quantification in the envenomed and control groups for uClust and uCysB, respectively. 
Because of this, imputation and rank-based procedures were used to handle the data. With 
such high levels of imputation used, there is a risk of not knowing the true distribution of the 
data. To mitigate this risk, a conservative form of imputation was applied using the limit of 
quantification (LOQ).  
 
Conclusion  
Our results show increased uClust and uCysB concentrations in dogs with snakebite 
envenomation by the European adder, suggesting renal tubular injury in the affected dogs. No 
increases were observed in the established markers of renal glomerular function, sCr and 
SDMA, highlighting the need for future studies on renal biomarkers in dogs.  
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Routine serum and urinary parameters and novel renal biomarkers in 25 snake-envenomed 
dogs and 13 healthy control dogs. 
 
 Snake-envenomed  
6 m, 5 mn, 10 f, 4 fn 
Healthy controls 
2 m, 2  mn, 3 f, 6 fn 
 
Category Median IQR  Median IQR Pa 
Age (years) 3.8 1.9 - 7.4 6.7 3.8 - 9.9 0.023 
Bodyweight 
(kg) 
19.0 9.4 - 25.7 22.5 8.7 - 29.1 0.451 
sCr ( 
µmol/L) 
61.6 44.0 - 70.4 70.4 61.6 - 88.0 0.948 
SDMA 
(µmol/L) 






70.0 70.0 – 70.0b 0.012 
uClust / uCr 697.3 
229.6 -
 4337.8 












46.7 21.1 - 56.8 0.001 
UPC 0.68 0.22 - 1.77 0.09 0.06 - 0.12 0.001 
USG 1.01 1.01 - 1.02 1.04 1.02 - 1.04 0.999 
 
m, male intact; mn, male neutered; f, female; fn, female neutered, uClust, urinary clusterin; 
uCysB, urinary cystatin B; sCr, serum creatinine; SDMA, symmetric dimethyl arginine; uCr, 
urinary creatinine; UPC, urine protein- creatinine ratio; USG, urine specific gravity. 
aP based off the Wilcoxon Rank Sum Test 
b In control dogs 76.9 % had uClust levels below the limit of detection and imputed at a value 




Correlation between age, bodyweight, renal biomarkers and UPC of 25 snake-envenomed 
and 13 healthy dogs  
 Spearman’s Correlation Coefficient 
 uClust (ng/dL) uClust /uCr  uCysB (ng/dL) uCysB /uCr  







Age (years) Envenomed -0.11 0.609 -0.369 0.077 -0.092 0.670 -0.408 0.049 
 Healthy -0.134 0.663 -0.055 0.863 -0.027 0.931 -0.071 0.821 
Bodyweight 
(kg) 
Envenomed -0.025 0.906 -0.183 0.381 -0.054 0.799 -0.161 0.441 
 Healthy -0.193 0.527 -0.669 0.012 0.222 0.467 -0.446 0.127 
sCr (µmol /L) Envenomed 0.465 0.019 0.383 0.059 0.210 0.313 0.084 0.689 
 Healthy -0.418 0.155 -0.596 0.032 -0.041 0.895 -0.496 0.085 
SDMA (µmol 
/L) 
Envenomed 0.107 0.612 0.170 0.417 0.038 0.856 0.071 0.735 
 Healthy -0.361 0.225 -0.034 0.913 -0.103 0.739 0.227 0.457 
uClust 
(ng/mL) 
Envenomed --- --- --- --- 0.749 <0.001 0.598 0.002 
 Healthy --- --- --- --- -0.354 0.235 -0.126 0.681 
uClust / uCr  Envenomed --- --- --- --- 0.706 <0.001 0.850 <0.001 
 Healthy --- --- --- --- -0.242 0.426 0.500 0.085 
uCysB 
(ng/mL) 
Envenomed 0.749 <0.001 0.706 <0.001 --- --- --- --- 
 Healthy -0.354 0.235 -0.242 0.426 --- --- --- --- 
uCysB / uCr  Envenomed 0.598 0.002 0.850 <0.001 --- --- --- --- 
 Healthy -0.126 0.681 0.500 0.085 --- --- --- --- 
UPC Envenomed 0.511 0.015 0.752 <0.001 0.671 <0.001 0.844 <0.001 
 Healthy 0.323 0.282 0.361 0.225 0.170 0.580 0.339 0.257 
          
          
uClust, urinary clusterin; uCysB, urinary cystatin B; sCr, serum creatinine; SDMA, 




Snakebite location and renal biomarkers in 25 snake-envenomed dogs 
 Head (N = 16) Limb (N = 8) Neck (N = 1)  
Category Median IQR Median IQR Median IQR Pa 
sCr (µmol/L) 61.6 44.0 - 70.4 57.2 50.6 - 79.2 35.2 35.2 - 35.2 0.512 
SDMA 
(µmol/L) 
2.9 2.5 - 3.6 2.4 1.8 - 3.7 1.8 1.8 - 1.8 0.830 










uCysB (ng/mL) 85.0 
47.3 -
 210.8 




aP based off the Wilcoxon Rank Sum Test. Comparison between Limb and Head only. 
 
SCr, serum creatinine; SDMA, symmetric dimethyl arginine; uClust, urinary clusterin; 
uCysB, urinary cystatin B 
  
 
Table 4  
Correlations of biomarker values by time from snake bite to sample collection 
 
 Spearman’s correlation coefficient  
Type Estimate 95% Confidence Interval P 
uClusterin vs. Time 0.521 0.163 - 0.768 0.009 
uCystatin B vs. Time 0.241 -0.160 - 0.600 0.139 
Note: A Spearman’s Correlation Test was conducted to compare distributions of the four biomarkers values 





















Fig. 1. Comparison of urinary clusterin (uClust) in snake-envenomed (n=25) and healthy 
control dogs (n=13). (A) uClust. (B)uClust normalized by urinary creatinine.   Whiskers 
represent 1.5 times the interquartile range.  
 
Fig. 2. Comparison of urinary cystatin B (uCysB) in snake-envenomed (n=25) and healthy 
control dogs (n=13). (A) uCysB. (B) uCysB normalized by urinary creatinine Whiskers 
represent 1.5 times the interquartile range. 
 
Fig. 3. Comparison of routine renal biomarkers in snake-envenomed (n=25) and healthy 
control dogs (n=13).  (A) Serum creatinine. (B) Symmetric dimethylarginine (SDMA). 
Whiskers represent 1.5 times the interquartile range. 
 
Fig. 4. Association between colloids and the renal biomarkers. (A) Urinary clusterin. (B) 
Urinary cystatin B. (C) Serum creatinine. (D) Symmetric dimethylarginine (SDMA).  
Whiskers represent 1.5 times the interquartile range. 
 
 
